Analysts who follow Scopus Biopharma Inc (SCPS) on average expect it to add 866.18% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns the stock an Analyst Ranking of 74, which means it ranks higher than 74 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating SCPS a Strong Buy today. Find out what this means to you and get the rest of the rankings on SCPS!
Why are Analyst Ratings Important?
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With Scopus Biopharma Inc Stock Today?
Scopus Biopharma Inc (SCPS) stock is trading at $2.07 as of 11:28 AM on Wednesday, Dec 8, a drop of -$0.09, or -4.17% from the previous closing price of $2.16. Volume today is high. So far 654,525 shares have traded compared to average volume of 44,517 shares. The stock has traded between $2.02 and $2.22 so far today.
Click Here to get the full Stock Report for Scopus Biopharma Inc stock.